Gossamer BioGOSS -2.82%16 Pretax Margin % is -275.22% as of Mar. 2026. GuruFocus rates GOSS with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 947 Biotechnology companies, Gossamer Bio ranks worse than 65.47% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Gossamer Bio's Pre-Tax Income for the
three
months ended in Mar. 2026 was $-46.66 Mil. Gossamer Bio's Revenue for the
three
months ended in Mar. 2026 was $16.96 Mil. Therefore, Gossamer Bio's pretax margin for the quarter that ended in Mar. 2026 was -275.22%.
The historical rank and industry rank for Gossamer Bio's Pretax Margin % or its related term are showing as below:
GOSS'
s Pretax Margin % Range Over the Past 10 Years
Min: -351.67 Med: -200.09 Max: -48.5
Current: -324.98
GOSS's Pretax Margin % is ranked worse than 65.47% of 947
companies
in the Biotechnology industry
Industry Median: -92.22
vs GOSS: -324.98
Gossamer Bio (NAS:GOSS) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Gossamer Bio Pretax Margin % Related Terms
Gossamer Bio Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Gossamer Bio's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GOSS vs TIL, ATYR, HYPD: Pretax Margin % Comparison
For the Biotechnology subindustry, Gossamer Bio's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gossamer Bio Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gossamer Bio's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Gossamer Bio's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gossamer Bio (GOSS) has a Pretax Margin % of -275.22% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Gossamer Bio and its competitors. According to the industry distribution chart, Gossamer Bio ranks #620 out of 947 companies in the Biotechnology industry, placing it in the top 65.5%.
Is Gossamer Bio's Pretax Margin % too high?
Gossamer Bio's current Pretax Margin % is -275.22%. Based on the distribution chart, Gossamer Bio ranks #620 out of 947 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Gossamer Bio has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's Pretax Margin % compare to TIL and ATYR?
According to the Biotechnology industry distribution chart, Gossamer Bio ranks #620 out of 947 companies for Pretax Margin %. This places Gossamer Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Gossamer Bio and its competitors. Gossamer Bio's current Pretax Margin % is -275.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current Pretax Margin % of -275.22%. The current Pretax Margin % is -275.22%. Gossamer Bio's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current Pretax Margin % is -275.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
16GF Score
Get the complete analysis for GOSS
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GOSS has been successfully added to your 
